METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N6 -methyladenosine-dependent primary MicroRNA processing
- PMID: 27774652
- DOI: 10.1002/hep.28885
METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N6 -methyladenosine-dependent primary MicroRNA processing
Abstract
N6 -Methyladenosine (m6 A) modification has been implicated in many biological processes. However, its role in cancer has not been well studied. Here, we demonstrate that m6 A modifications are decreased in hepatocellular carcinoma, especially in metastatic hepatocellular carcinoma, and that methyltransferase-like 14 (METTL14) is the main factor involved in aberrant m6 A modification. Moreover, METTL14 down-regulation acts as an adverse prognosis factor for recurrence-free survival of hepatocellular carcinoma and is significantly associated with tumor metastasis in vitro and in vivo. We confirm that METTL14 interacts with the microprocessor protein DGCR8 and positively modulates the primary microRNA 126 process in an m6 A-dependent manner. Further experiments show that microRNA 126 inhibits the repressing effect of METTL14 in tumor metastasis.
Conclusion: These studies reveal an important role of METTL14 in tumor metastasis and provide a fresh view on m6 A modification in tumor progression. (Hepatology 2017;65:529-543).
© 2016 by the American Association for the Study of Liver Diseases.
Similar articles
-
Analysis of METTL3 and METTL14 in hepatocellular carcinoma.Aging (Albany NY). 2020 Nov 6;12(21):21638-21659. doi: 10.18632/aging.103959. Epub 2020 Nov 6. Aging (Albany NY). 2020. PMID: 33159022 Free PMC article.
-
METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.Mol Cancer. 2020 Jun 17;19(1):106. doi: 10.1186/s12943-020-01220-7. Mol Cancer. 2020. PMID: 32552762 Free PMC article.
-
ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1.Mol Cancer. 2020 Aug 10;19(1):123. doi: 10.1186/s12943-020-01239-w. Mol Cancer. 2020. PMID: 32772918 Free PMC article.
-
Roles of M6A Regulators in Hepatocellular Carcinoma: Promotion or Suppression.Curr Gene Ther. 2022;22(1):40-50. doi: 10.2174/1566523221666211126105940. Curr Gene Ther. 2022. PMID: 34825870 Review.
-
Functions, mechanisms, and therapeutic implications of METTL14 in human cancer.J Hematol Oncol. 2022 Feb 3;15(1):13. doi: 10.1186/s13045-022-01231-5. J Hematol Oncol. 2022. PMID: 35115038 Free PMC article. Review.
Cited by
-
The m6A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m6A-Dependent Manner.Front Cell Dev Biol. 2021 Mar 15;9:647702. doi: 10.3389/fcell.2021.647702. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33791305 Free PMC article.
-
Methyl CpG binding protein 2 promotes colorectal cancer metastasis by regulating N6 -methyladenosine methylation through methyltransferase-like 14.Cancer Sci. 2021 Aug;112(8):3243-3254. doi: 10.1111/cas.15011. Epub 2021 Jun 29. Cancer Sci. 2021. PMID: 34097350 Free PMC article.
-
Mettl14 mutation restrains liver regeneration by attenuating mitogens derived from non-parenchymal liver cells.BMB Rep. 2022 Dec;55(12):633-638. doi: 10.5483/BMBRep.2022.55.12.140. BMB Rep. 2022. PMID: 36284441 Free PMC article.
-
Advances in epigenetic therapeutics with focus on solid tumors.Clin Epigenetics. 2021 Apr 20;13(1):83. doi: 10.1186/s13148-021-01069-7. Clin Epigenetics. 2021. PMID: 33879235 Free PMC article. Review.
-
miR-340-3p-modified bone marrow mesenchymal stem cell-derived exosomes inhibit ferroptosis through METTL3-mediated m6A modification of HMOX1 to promote recovery of injured rat uterus.Stem Cell Res Ther. 2024 Jul 29;15(1):224. doi: 10.1186/s13287-024-03846-6. Stem Cell Res Ther. 2024. PMID: 39075530 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
